https://www.selleckchem.com/pr....oducts/gsk2256098.ht
Objectives To assess functional expression of the P2Y2 nucleotide receptor (P2Y2R) in head and neck squamous cell carcinoma (HNSCC) cell lines and define its role in nucleotide-induced epidermal growth factor receptor (EGFR) transactivation. The use of anti-EGFR therapeutics to treat HNSCC is hindered by intrinsic and acquired drug resistance. Defining novel pathways that modulate EGFR signaling could identify additional targets to treat HNSCC. Materials and methods In human HNSCC cell lines CAL27 and FaDu and the mouse oral cancer c
Like
Comment
Share
